US Merger & Acquisition SEC Filings — March 10, 2026

10-03-2026

Crown PropTech Acquisitions adopted its Sixth Amended and Restated Memorandum and Articles of Association via special resolution on March 9, 2026, filed in an 8-K on March 10, 2026. The amendments specify share capital of US$22,100 divided into 200,000,000 Class A ordinary shares (par US$0.0001), 20,000,000 Class B ordinary shares (par US$0.0001), and 1,000,000 preference shares (par US$0.0001), with no changes to par values or flat performance in capital structure noted. Standard SPAC provisions reaffirmed include business combinations targeting at least 80% of Trust Account net assets and a 15% over-allotment option.

• ·Registered office at Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands

10-03-2026

On March 10, 2026, the underwriters of GalaxyEdge Acquisition Corp.'s IPO fully exercised their over-allotment option, purchasing 1,500,000 additional units at $10.00 per unit for additional gross proceeds of $15 million. This increased total IPO units to 11,500,000 and aggregate gross proceeds to $115 million. A press release announcing the exercise is attached as Exhibit 99.1.

• ·Registrant is an emerging growth company.
• ·Principal executive offices: 1185 Avenue of the Americas, Suite 349, New York, NY 10036.

10-03-2026

Ashford Hospitality Trust, Inc. completed the sale of its 333-room St. Petersburg Hilton Bayfront hotel on March 5, 2026, for $95.3M in cash net of selling expenses, with proceeds used to pay down approximately $94.7M on a mortgage loan secured by 12 hotels. Pro forma balance sheet as of September 30, 2025, reflects reduced total assets to $2.99B from $3.01B and indebtedness to $2.52B from $2.61B, improving the equity deficit to $453M from $533M. Pro forma 2024 operations show revenue declining 2% to $1.15B but net loss to common stockholders improving 94% to $5.3M from $82.5M due to a preliminary gain; however, nine-month 2025 pro forma net loss to common stockholders slightly worsens to $137.6M from $136.7M.

• ·Mortgage loan partially repaid is secured by 12 hotels including the sold property.
• ·Pro forma gain on disposition of $79.6M for 2024 is preliminary and may differ from actual.
• ·No tax effects reflected in pro forma operations.

10-03-2026

byNordic Acquisition Corp (BYNOW), a SPAC targeting high technology growth companies in northern Europe, deposited $17,470 into its Trust Account on March 6, 2026, extending the deadline to complete its initial business combination from March 12, 2026, to April 12, 2026. This is the eighth of up to twelve one-month extensions permitted under the August 2025 charter amendment, avoiding near-term liquidation. No financial results or declines reported.

• ·Securities trade on OTC Pink Limited Market
• ·Warrants exercisable at $11.50 per share of Class A common stock (par value $0.0001)
• ·Maximum extensions until August 12, 2026, or business combination closing
• ·Annual stockholder meeting held August 6, 2025, for initial extension approval

10-03-2026

Acura Pharmaceuticals, Inc. amended the loan schedule to its Secured Promissory Note originally dated November 10, 2022, with Abuse Deterrent Pharma, LLC, incorporating additional loans #1-#50 totaling $7.075M from December 22, 2022, to December 31, 2025, for an aggregated principal of $9.394M prior to recent additions. Loans #51-#55, each $100,000 and dated January 2 to March 9, 2026, increased the total principal to $9.894M. The amendment was executed on March 9, 2026, by Robert A. Seiser, Senior Vice President & CFO.

• ·Loan #51 dated 1/02/2026: $100,000 (total $9,494,279)
• ·Loan #52 dated 1/16/2026: $100,000 (total $9,594,279)
• ·Loan #53 dated 2/06/2026: $100,000 (total $9,694,279)
• ·Loan #54 dated 2/13/2026: $100,000 (total $9,794,279)
• ·Loan #55 dated 3/09/2026: $100,000 (total $9,894,279)

10-03-2026

On March 10, 2026, X3 Acquisition Corp. Ltd., a Cayman Islands-incorporated SPAC, announced that starting on or about March 13, 2026, holders of its units (XCBEU) may elect to separately trade the underlying Class A ordinary shares (XCBE) and redeemable warrants (XCBEW) on Nasdaq. Unseparated units will continue trading under XCBEU, and holders must contact transfer agent Continental Stock Transfer & Trust Company to separate them. This is a standard post-IPO procedural step with no financial impact disclosed.

• ·Company is an emerging growth company.
• ·Principal executive offices: 3033 Excelsior Blvd Suite 343, Minneapolis, MN 55416.
• ·Telephone number: 612-457-0070.
• ·Commission File Number: 001-43061; I.R.S. Employer Identification Number: 98-1877158.

10-03-2026

Klotho Neurosciences, Inc. authorized 50,000 shares of Series C Preferred Stock via board resolution on March 4, 2026, filed in 8-K on March 10, 2026. Each Series C share is convertible into 42,554 common shares (potential 2.13B common shares total) only after Nasdaq-required stockholder approval, with no voting or conversion rights prior. The stock carries as-converted dividends and liquidation preferences but no independent voting until approval.

• ·Stockholder Approval required for voting rights (on as-converted basis) and conversions per Nasdaq rules
• ·Liquidation notice to holders: at least 30 days prior to payment date
• ·No fractional common shares on conversion; cash payment for fractions
• ·Conversion Ratio adjusts for stock splits, combinations, reorganizations

10-03-2026

FutureTech II Acquisition Corp. entered into a financial advisory engagement letter with D. Boral Capital, LLC on March 4, 2026, granting it a 36-month right of first refusal for future equity/debt offerings and M&A advisory post-closing of its De-SPAC business combination with Longevity Biomedical, Inc. The company also executed a corrected promissory note for $1.475M as part of settling the $3.45M deferred IPO underwriting commission, payable contingent on the business combination closing, alongside $0.5M cash and 147,500 shares valued at $10/share. These agreements support the ongoing merger process announced via Form S-4 on February 14, 2025, with no financial performance impacts disclosed.

• ·Engagement letter provides irrevocable right of first refusal for 36 months post-closing.
• ·Corrected promissory note obligation is contingent upon business combination closing.
• ·Original Discharge Agreement and promissory note disclosed in 8-K on February 11, 2025.
• ·IPO underwriting agreement dated February 15, 2022.

10-03-2026

Eventbrite, Inc. adopted an Amended and Restated Certificate of Incorporation, drastically reducing authorized common stock to 100 shares with a $0.01 par value per share, likely as part of a merger or going-private transaction. The 8-K includes items for acquisition completion (2.01), change in control (5.01), director departures and elections (5.02, 5.03), delisting notice (3.01), and material agreement termination (1.02), with no financial performance data disclosed. No period-over-period comparisons or operating metrics are provided.

• ·Registered office: 3500 South DuPont Highway, City of Dover, County of Kent 19901, Delaware.
• ·Standard provisions added for director/officer liability limitations and indemnification under DGCL.

10-03-2026

On February 24, 2026, Brian Coad resigned from the Board of Directors of Piermont Valley Acquisition Corp, with the resignation explicitly stated as not resulting from any disagreement on the Company's operations, policies, or practices. The 8-K filing was submitted on March 10, 2026, and signed by Wei Qian, Chairman and Chief Executive Officer. No replacement director or officer was announced.

10-03-2026

Lake Superior Acquisition Corp., a SPAC, announced it has entered into a definitive Plan of Merger and Business Combination Agreement with Openmarkets Group Pty Ltd and BMYG OMG Pty Ltd to pursue a business combination. An investor presentation detailing the proposed transactions is furnished as Exhibit 99.1 under Item 7.01. The filing emphasizes extensive risks, including potential failure to obtain shareholder or regulatory approvals, and states that the information is not filed for liability purposes.

• ·Filing references Lake Superior's IPO prospectus dated October 7, 2025.
• ·Upcoming filings include Registration Statement on Form F-4 with proxy statement/prospectus.
• ·Securities traded: Units (LKSPU), Class A Ordinary Shares (LKSP), Rights (LKSPR) on NASDAQ.

10-03-2026

Strategic Acquisitions Inc. issued 30M restricted common shares to John P. O’Shea and 10M to Jennifer L. O’Shea at $0.001 per share for past services on Feb 4, 2026, boosting John's ownership from 151,800 to 30.15M shares (64.6% of 46.675M outstanding) and giving Jennifer 21.4%, representing significant dilution for existing shareholders. The company engaged new auditor Integritat Audit on Feb 28, 2026, accepted resignations from directors Wei Huang (Jan 18) and Yuanyuan Huang (Feb 3), and appointed Jennifer L. O’Shea to the board on Feb 18. These governance shifts followed a temporary SEC registration termination via Form 15 (filed Dec 23, 2025, rescinded Feb 23, 2026).

• ·Shares issued under Section 4(2) exemption with transfer restrictions.
• ·No prior consultations or disagreements with new auditor Integritat Audit.
• ·No disagreements cited in resignations of Wei Huang and Yuanyuan Huang.
• ·Company address: 2464 Darts Cove Way, Mount Pleasant, Charleston, South Carolina 29466-0101.